nanoparticle therapeutics

EnduRx Pharmaceuticals Inc. is a virtual, pre-clinical company developing a peptide-directed polymeric nanoparticle drug delivery platform and therapeutics for hard-to-treat solid tumors and selected other indications. Its candidates are designed to achieve tumor-specific delivery of active pharmaceutical ingredients while avoiding healthy tissue. The company is led by experienced life science executives and scientists and utilizes resources across the US, with a corporate office in Tucson, AZ.

Read more

drug delivery platform developmentpre-clinical research